Successful treatment with dupilumab for mucus plugs in severe asthma.
Moriyasu AnaiChieko YoshidaHiroki IzumiKei MuramotoKoichi SaruwatariYusuke TomitaHidenori IchiyasuTakuro SakagamiPublished in: Respirology case reports (2022)
A 29-year-old man presented to our hospital with severe eosinophilic asthma. He needed a short OCS burst for exacerbation of asthma once every 1 or 2 months, although he used a high dose of inhaled corticosteroids and a long-acting beta-2 agonists. Chest CT showed multiple mucous plugs with bronchiectasis, but further examination found that he did not meet the diagnostic criteria for allergic bronchopulmonary aspergillosis. After starting dupilumab for his severe eosinophilic asthma, his asthma control improved without exacerbation. Furthermore, most mucus plugs disappeared on chest CT after 16 weeks from initiating dupilumab. This case suggests that dupilumab may be an effective treatment against mucus plugs associated with severe eosinophilic asthma.
Keyphrases
- chronic obstructive pulmonary disease
- atopic dermatitis
- lung function
- allergic rhinitis
- cystic fibrosis
- high dose
- computed tomography
- early onset
- healthcare
- magnetic resonance imaging
- dual energy
- contrast enhanced
- drug induced
- intensive care unit
- positron emission tomography
- extracorporeal membrane oxygenation
- electronic health record